MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

Brief description of study

This study aims to evaluate the safety and tolerability of MK-7625A (ceftolozane/tazobactam) plus metronidazole, compared with that of meropenem in pediatric participants with cIAI.

Clinical Study Identifier: NCT03217136

Start Over

Universiti Kebangsaan Malaya Medical Centre ( Site 1101)

Cheras, Malaysia

3.86miles

University Malaya Medical Centre. ( Site 1100)

Kuala Lumpur, Malaysia

5.26miles

View all locations

MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

Brief description of study

Universiti Kebangsaan Malaya Medical Centre ( Site 1101)

University Malaya Medical Centre. ( Site 1100)

Volunteer Sign-up